Log In
Print this Print this

PyroMark KRAS Kit

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionK-Ras mutation test that runs on the PyroMark Q24 MDx system
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetection and quantification of mutations in the KRAS codons 12, 13, and 61
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today